The US experience with COVID-19
Robin Avery
Professor of Medicine,
Division of Infectious Diseases, Johns Hopkins
Baltimore, USA
Robin Avery MD, FIDSA, FAST, has been in the field of Transplant Infectious Disease for 27 years. She is currently Professor of Medicine in the Division of Infectious Diseases (Transplant/Oncology ID Program) at Johns Hopkins. She is a past chair of the AST ID Community of Practice, was founding Section Head for Transplant ID and the Transplant ID Fellowship at Cleveland Clinic, and has served on multiple guidelines committees. Her areas of interest are transplant-related viral infections, resistant/refractory CMV, incompatible kidney transplant recipients, chronic norovirus, strategies for safer living after transplant, ID Fellow education, and patient education.
The Italian experience with COVID-19
Paolo Antonio Grossi
Professor of Infectious Diseases
University of Insubria
Varese, Italy
Paolo Grossi is Professor of Infectious Diseases at the University of Insubria in Varese, Italy. Since the beginning of his career, he performed his clinical and research activity at the Infectious Diseases Department of the University of Pavia. In 1993 he moved, as visiting professor, to the University of Pittsburgh, Pennsylvania where he remained until the end of 1994. Since the year 2000 he is professor of Infectious Diseases and director of the residency programs in Infectious Diseases and until 2019 of Hygiene and Preventive Medicine at the University of Insubria, Varese, Italy. From February 2001 he is the Director of the Infectious and Tropical Diseases Department of the Ospedale di Circolo and Fondazione Macchi of Varese, Italy, where, from April 2009 to December 2019 he was the Director of the Department of Transplantation.
The main research interest is in the field of infectious complications in transplant recipients and he participated in many research projects in this area. He is the author or co-author of more than 200 publications in the field of infectious disease in immunocompromised patients. From 1999 he is the advisor for all infectious diseases related problems at the Italian National Centre for Transplantation in Italy and covers the role of “second opinion” for all organ donors with potentially transmissible infectious diseases. Since 2001 he is a member of the Steering Committee of the program of Liver, kidney, kidney-pancreas, Lung and Heart transplantation in HIV+ individuals in Italy. In April 2013 he was elected co-Chair of the ID Council of the International Society of Heart and Lung Transplantation and subsequently chair of the ID committee. He is currently the past chair of the ID council of ISHLT. From April 2019 he is the chair of the ESCMID study group on infections in immunocompromised host (ESGICH). In July 2013 he was nominated member of the WHO International Health Regulations Roster of Experts, as an expert in Essential health technologies (Transplantation services).
The North America Series is kindly sponsored by:
